MedTrace Logo

Psoriatic Arthritis Research Collaborative: Biologic Sub-Study

NCT03378336 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 171

Last updated 2025-05-09

Study results available
· View outcomes & findings →

Summary

Psoriatic arthritis (PsA) is an inflammatory arthritis with substantial variation in clinical features. We propose a multicenter collaborative approach to better understand the phenotypes and current management of PsA in the United States.The central goal of this proposal is to obtain the data necessary to design a pragmatic trial in PsA.

Conditions

Sponsors & Collaborators

Principal Investigators

  • Alexis Ogdie, MD · University of Pennsylvania

Eligibility

Min Age
18 Years
Max Age
89 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-12-31
Primary Completion
2023-08-16
Completion
2023-08-16

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03378336 on ClinicalTrials.gov